179 related articles for article (PubMed ID: 33066813)
1. Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer.
Wang H; Chong T; Li BY; Chen XS; Zhen WB
Biol Res; 2020 Oct; 53(1):46. PubMed ID: 33066813
[TBL] [Abstract][Full Text] [Related]
2.
Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
[TBL] [Abstract][Full Text] [Related]
3. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients.
Shi H; Fang X; Li Y; Zhang Y
Med Sci Monit; 2019 Oct; 25():7430-7438. PubMed ID: 31581160
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y
Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119
[TBL] [Abstract][Full Text] [Related]
5. Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma.
Luo L; Zheng Y; Lin Z; Li X; Li X; Li M; Cui L; Luo H
J Immunol Res; 2021; 2021():6647122. PubMed ID: 33928169
[TBL] [Abstract][Full Text] [Related]
6. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.
Ji L; Tang Y; Pang X; Zhang Y
Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360
[TBL] [Abstract][Full Text] [Related]
7. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers.
Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS
Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455
[TBL] [Abstract][Full Text] [Related]
8. miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma.
Wu X; Deng L; Tang D; Ying G; Yao X; Liu F; Liang G
Tumour Biol; 2016 May; 37(5):6813-21. PubMed ID: 26662310
[TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
Bernhardt S; Bayerlová M; Vetter M; Wachter A; Mitra D; Hanf V; Lantzsch T; Uleer C; Peschel S; John J; Buchmann J; Weigert E; Bürrig KF; Thomssen C; Korf U; Beissbarth T; Wiemann S; Kantelhardt EJ
Breast Cancer Res; 2017 Oct; 19(1):112. PubMed ID: 29020998
[TBL] [Abstract][Full Text] [Related]
10. NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients.
Liu L; Lan G; Peng L; Xie X; Peng F; Yu S; Wang Y; Tang X
Ren Fail; 2016 Sep; 38(8):1199-205. PubMed ID: 27453328
[TBL] [Abstract][Full Text] [Related]
11. Expression profile and prognostic value of SFN in human ovarian cancer.
Hu Y; Zeng Q; Li C; Xie Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30926680
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of NDUFA4L2 is associated with poor prognosis in patients with colorectal cancer.
Lv Y; Nie SL; Zhou JM; Liu F; Hu YB; Jiang JR; Li N; Liu JS
ANZ J Surg; 2017 Dec; 87(12):E251-E255. PubMed ID: 27226356
[TBL] [Abstract][Full Text] [Related]
13. SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression.
Cui X; Cui Y; Du T; Jiang X; Song C; Zhang S; Ma C; Liu Y; Ni Q; Gao Y; Wang G
Can J Gastroenterol Hepatol; 2022; 2022():3758697. PubMed ID: 35211429
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma.
Wang B; Wang W; Zhu Z; Zhang X; Tang F; Wang D; Liu X; Yan X; Zhuang H
Clin Neurol Neurosurg; 2017 Mar; 154():28-33. PubMed ID: 28107674
[TBL] [Abstract][Full Text] [Related]
15. Cancer proteome and metabolite changes linked to SHMT2.
Tong J; Krieger JR; Taylor P; Bagshaw R; Kang J; Jeedigunta S; Wybenga-Groot LE; Zhang W; Badr H; Mirhadi S; Pham NA; Coyaud É; Yu M; Li M; Cabanero M; Raught B; Maynes JT; Hawkins C; Tsao MS; Moran MF
PLoS One; 2020; 15(9):e0237981. PubMed ID: 32903271
[TBL] [Abstract][Full Text] [Related]
16. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis.
Wei Z; Song J; Wang G; Cui X; Zheng J; Tang Y; Chen X; Li J; Cui L; Liu CY; Yu W
Nat Commun; 2018 Oct; 9(1):4468. PubMed ID: 30367038
[TBL] [Abstract][Full Text] [Related]
17. SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT.
Huo FC; Xie M; Zhu ZM; Zheng JN; Pei DS
Genomics; 2022 Jul; 114(4):110424. PubMed ID: 35798250
[TBL] [Abstract][Full Text] [Related]
18. Serine hydroxymethyltransferase 2 knockdown induces apoptosis in ccRCC by causing lysosomal membrane permeabilization via metabolic reprogramming.
Liu Z; Fan M; Hou J; Pan S; Xu Y; Zhang H; Liu C; Hao X; Li X; Wang H
Cell Death Dis; 2023 Feb; 14(2):144. PubMed ID: 36806313
[TBL] [Abstract][Full Text] [Related]
19. High expression of SHMT2 is correlated with tumor progression and predicts poor prognosis in gastrointestinal tumors.
Liu Y; Yin C; Deng MM; Wang Q; He XQ; Li MT; Li CP; Wu H
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9379-9392. PubMed ID: 31773687
[TBL] [Abstract][Full Text] [Related]
20. SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation.
Yang X; Wang Z; Li X; Liu B; Liu M; Liu L; Chen S; Ren M; Wang Y; Yu M; Wang B; Zou J; Zhu WG; Yin Y; Gu W; Luo J
Cancer Res; 2018 Jan; 78(2):372-386. PubMed ID: 29180469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
